Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The yeast 2-micron circle plasmid encodes a protein,
FLP
, that mediates site-specific recombination across the two
FLP
-binding sites of the plasmid. We have used a novel technique, "exonuclease-treated substrate analysis," to determine the minimal duplex DNA sequence needed for this recombination event. A linear DNA containing two
FLP
sites in a direct orientation was treated with the double-strand specific 3'-exonuclease, exonuclease III, to generate molecules with a nested set of single-strand deletions that extended into one of the
FLP
sites. The DNA was then end-labeled at the sites of the deletions and used as a substrate for recombination in vitro.
FLP
-mediated recombination between two
FLP
sites excised a restriction endonuclease cleavage site from the DNA. Comparison of the fragments produced by restriction enzyme digestion of untreated and
FLP
-treated DNA showed to the nucleotide the duplex DNA sequence required for
FLP
-mediated recombination. To examine essential sequences in the opposite DNA strand, similar experiments were done using the
5'-exonuclease
encoded by phage T7. The minimal essential duplex DNA sequence lies within the region of the
FLP
site that was previously shown to be protected from nuclease digestion in the presence of
FLP
. A modified form of this technique can be used to study the minimal sequence requirements of site-specific DNA binding proteins.
...
PMID:Determination of DNA sequences essential for FLP-mediated recombination by a novel method. 299 71
Monitoring of neuronal activity within circuits facilitates integrated responses and rapid changes in behavior. We have identified a system in Caenorhabditis elegans where neuropeptide expression is dependent on the ability of the BAG neurons to sense carbon dioxide. In C. elegans, CO
2
sensing is predominantly coordinated by the BAG-expressed receptor-type guanylate cyclase GCY-9. GCY-9 binding to CO
2
causes accumulation of cyclic GMP and opening of the cGMP-gated TAX-2/TAX-4 cation channels; provoking an integrated downstream cascade that enables C. elegans to avoid high CO
2
. Here we show that cGMP regulation by GCY-9 and the PDE-1
phosphodiesterase
controls BAG expression of a FMRFamide-related neuropeptide
FLP
-19 reporter (flp-19::GFP). This regulation is specific for CO
2
-sensing function of the BAG neurons, as loss of oxygen sensing function does not affect flp-19::GFP expression. We also found that expression of flp-19::GFP is controlled in parallel to GCY-9 by the activity-dependent transcription factor CREB (CRH-1) and the cAMP-dependent protein kinase (KIN-2) signaling pathway. We therefore show that two parallel pathways regulate neuropeptide gene expression in the BAG sensory neurons: the ability to sense changes in carbon dioxide and CREB transcription factor. Such regulation may be required in particular environmental conditions to enable sophisticated behavioral decisions to be performed.
...
PMID:Control of Neuropeptide Expression by Parallel Activity-dependent Pathways in Caenorhabditis elegans. 2813 92